Publications, Pharmaceutical

Derisking the Development of Prefilled Syringe Delivery

Primary packaging plays a critical role in the development and delivery of every injectable drug and offers many opportunities to meet increasing market expectations. Primary packaging manufacturers are continually improving their processes to de­velop innovative solutions, such as rubber components laminated with fluorinated films (i.e. ETFE).

Donwload Publication on Derisking the development of prefilled syringe delivery
Author(s): C. Raynal-Olive
4 May 2022

In this edition of Drug Development & Delivery, discover our PremiumCoat® platform of ETFE-film coated solutions. Claire Raynal-Olive explains how these vial stoppers and pre-filled syringe plungers protect sensitive drugs and help derisk product development to reach the market faster.

Learn more about Aptar Pharma Expertise
in Injectable Drug Delivery

Find Out More in Injectable Drug Delivery

This Might Also Be of Interest

18 Jan 2024

Exploring Extractable and Leachable Testing Strategies for Parenterals

Publications, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
18 Dec 2023

Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
13 Oct 2023

Aptar Pharma Injectable Expansion – Capacity, Capabilities and Partnership

Publications, Pharmaceutical, Market Insights, Product Solutions

Read More
13 Oct 2023

Injectable Primary Packaging support compliance with Annex 1 Revision

Publications, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions

Read More
1 2 3 4 5 6 14

Request Access

Close

Requesting access to Derisking the Development of Prefilled Syringe Delivery.

  • This field is for validation purposes and should be left unchanged.
Back To Top